BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28754487)

  • 1. Recombinant Gallid herpesvirus 2 with interrupted meq genes confers safe and efficacious protection against virulent field strains.
    Zhang Y; Liu C; Yan F; Liu A; Cheng Y; Li Z; Sun G; Lv H; Wang X
    Vaccine; 2017 Aug; 35(36):4695-4701. PubMed ID: 28754487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
    Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
    Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
    Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
    Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
    Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
    Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome.
    Ralapanawe S; Walkden-Brown SW; Renz KG; Islam AF
    Avian Pathol; 2016; 45(1):26-37. PubMed ID: 26503904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
    Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
    Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of a recombinant Marek's disease virus lacking the meq oncogene and evaluation on its immune efficacy against Marek's disease virus.
    Sun P; Cui N; Liu L; Su S; Cheng Z; Chen R; Li Y; Cui Z
    Poult Sci; 2020 Apr; 99(4):1939-1945. PubMed ID: 32241474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination-challenge interval markedly influences protection provided by Rispens CVI988 vaccine against very virulent Marek's disease virus challenge.
    Islam T; Walkden Brown SW; Renz KG; Fakhrul Islam AF; Ralapanawe S
    Avian Pathol; 2013 Dec; 42(6):516-26. PubMed ID: 24098951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
    Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
    Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of a meq-deleted rmd5 Marek's disease vaccine: protection against virulent MDV challenge and induction of lymphoid organ atrophy are simultaneously attenuated by serial passage in vitro.
    Lee LF; Kreager K; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
    Avian Dis; 2013 Jun; 57(2 Suppl):491-7. PubMed ID: 23901766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic characteristics of Marek's disease virus field strains prevalent in China and the effectiveness of existing vaccines against them.
    Zhang YP; Li ZJ; Bao KY; Lv HC; Gao YL; Gao HL; Qi XL; Cui HY; Wang YQ; Ren XG; Wang XM; Liu CJ
    Vet Microbiol; 2015 May; 177(1-2):62-8. PubMed ID: 25770895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
    Buscaglia C; Nervi P; Risso M
    Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Common Live-Attenuated Avian Herpesvirus Vaccine Expresses a Very Potent Oncogene.
    Conradie AM; Bertzbach LD; Bhandari N; Parcells M; Kaufer BB
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31597721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation between pathogenic serotype 1 isolates of Marek's disease virus and the Rispens CVI988 vaccine in Australia using real-time PCR and high resolution melt curve analysis.
    Renz KG; Cheetham BF; Walkden-Brown SW
    J Virol Methods; 2013 Jan; 187(1):144-52. PubMed ID: 23041147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fully Attenuated
    Sun A; Zhao X; Zhu X; Kong Z; Liao Y; Teng M; Yao Y; Luo J; Nair V; Zhuang G; Zhang G
    Microbiol Spectr; 2022 Dec; 10(6):e0287122. PubMed ID: 36350141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.
    Chang S; Xie Q; Dunn JR; Ernst CW; Song J; Zhang H
    Vaccine; 2014 Apr; 32(16):1820-7. PubMed ID: 24530405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease.
    Witter RL; Kreager KS
    Avian Dis; 2004 Dec; 48(4):768-82. PubMed ID: 15666858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant field strain of Marek's disease (MD) virus with reticuloendotheliosis virus long terminal repeat insert lacking the meq gene as a vaccine against MD.
    Su S; Cui N; Zhou Y; Chen Z; Li Y; Ding J; Wang Y; Duan L; Cui Z
    Vaccine; 2015 Jan; 33(5):596-603. PubMed ID: 25562789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral kinetics, shedding profile, and transmission of serotype 1 Marek's disease vaccine Rispens/CVI988 in maternal antibody-free chickens.
    Islam T; Renz KG; Walkden-Brown SW; Ralapanawe S
    Avian Dis; 2013 Jun; 57(2 Suppl):454-63. PubMed ID: 23901761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential amplification of Marek's disease CVI988 vaccine and of wild-type isolates from organs of commercial chickens using single or duplexed probes in real-time PCR.
    Davidson I; Natour-Altoury A; Raibstein I; Dahan Y
    Avian Pathol; 2017 Dec; 46(6):610-614. PubMed ID: 28532188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.